Sector valuations DaShenLin Pharmaceutical Group Co., Ltd.
Stocks
603233
CNE100002RG2
Drug Retailers
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.80 CNY | -7.04% |
|
-8.36% | -16.00% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 11.35x | 2.13x | 0.55x | 0.44x | 3.55x | 5.85x | 6.09% | 2.48B | |
| 15.1x | 1.33x | 1.86x | 0.56x | 8.88x | 9.53x | -.--% | 13.03B | |
| 19.05x | 2.32x | 0.33x | 0.91x | 14.09x | 14.41x | -.--% | 6.33B | |
| 15.69x | 1.64x | 1.8x | 0.7x | 7.26x | 9.16x | 2.38% | 5.8B | |
| 11.47x | 1.73x | 0.69x | 0.72x | 5.17x | 6.76x | 3.74% | 3.24B | |
| 14.57x | 4.37x | 13.87x | 1.23x | 7.5x | 14.54x | 5.68% | 3.26B | |
| 15.22x | 6.89x | 2.33x | 0.92x | 6.88x | 9.56x | 4.24% | 3.14B | |
| 41.28x | - | 1.31x | - | - | - | - | 2.68B | |
| 23.85x | 4.17x | 1.03x | 0.68x | 8.74x | 14.31x | 1.72% | 1.74B | |
| -85.16x | 2.8x | 1.43x | 0.45x | 16.73x | 101.16x | 0.01% | 1.48B | |
| 46.88x | 5.15x | 1.11x | 1.37x | 15.8x | 30.27x | - | 1.06B | |
| 11.78x | 2.37x | -4.2x | 0.87x | 7.06x | 13.32x | 5.63% | 982M | |
| 10.58x | 0.75x | 0.1x | 0.24x | 2.34x | 4.83x | 4.8% | 834M | |
| 27.06x | 7.31x | 1.04x | 0.98x | 13.35x | 21.11x | 1.33% | 803M | |
| 12.7x | 1.71x | 1.05x | 0.63x | 7.69x | 12.41x | 0.41% | 624M | |
| Average | 12.76x | 3.19x | 1.62x | 0.76x | 8.93x | 19.09x | 2.77% | 3.17B | |
| Weighted average by Cap. | 14.64x | 2.57x | 2.09x | 0.74x | 8.92x | 14.08x | 1.98% |
Select your edition
All financial news and data tailored to specific country editions
